Combination of guided osteogenesis with autologous platelet-rich fibrin glue and mesenchymal stem cell for mandibular reconstruction

Journal of Trauma - Injury, Infection and Critical Care

Volumn 70, Issue 1, 2011, Pages 228-237

  Liao, Han Tsung ^a,b   Chen, Chien Tzung ^a   Chen, Chih Hao ^a,b   Chen, Jyh Ping ^b   Tsai, Jui Che ^c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c TATUNG UNIVERSITY   (Taiwan)

Author keywords

Bone marrow mesenchymal stem cell; Fibrin glue; Guided tissue osteogenesis; Platelet rich plasma

Indexed keywords

AUTOLOGOUS PLATELET RICH FIBRIN GLUE; FIBRIN GLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE GRAFT; BONE REGENERATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL STRUCTURE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; DOG; HISTOPATHOLOGY; JAW MALFORMATION; MANDIBLE; MANDIBLE RECONSTRUCTION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; TISSUE REGENERATION; X RAY ANALYSIS;

ANIMALS; BLOOD PLATELETS; BONE REGENERATION; DISEASE MODELS, ANIMAL; DOGS; FIBRIN TISSUE ADHESIVE; FRACTURE HEALING; GUIDED TISSUE REGENERATION; MANDIBLE; MANDIBULAR FRACTURES; MESENCHYMAL STEM CELLS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78751618781     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181e12b56     Document Type: Article

References (48)

1. Cricchio G, Lundgren S. Donor site morbidity in two different ap-proaches to anterior iliac crest bone harvesting. Clin Implant Dent Relat Res. 2003;5:161-169.
2. Silber JS, Anderson DG, Daffner SD, et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical disc-ectomy and fusion. Spine (Phila Pa 1976). 2003;28:134-139.
3. Van Gemert JT, van Es RJ, Van Cann EM, Koole R. Nonvascularized bone grafts for segmental reconstruction of the mandible\a reappraisal. JOral Maxillofac Surg. 2009;67:1446-1452.
4. Sbordone L, Toti P, Menchini-Fabris GB, Sbordone C, Piombino P, Guidetti F. Volume changes of autogenous bone grafts after alveolar ridge augmentation of atrophic maxillae and mandibles. Int J Oral Maxillofac Surg. 2009;38:1059-1065.
5. Lew D, Farrell B, Bardach J, Keller J. Repair of craniofacial defects with hydroxyapatite cement. J Oral Maxillofac Surg. 1997;55:1441-1449; discussion 1449-1451.
6. Eppley BL. Hydroxyapatite cranioplasty: I. Experimental results from a new quick-setting material. J Craniofac Surg. 2003;14:85-88.
7. Eppley BL, Hollier L, Stal S. Hydroxyapatite cranioplasty: 2. Clinical experience with a new quick-setting material. J Craniofac Surg. 2003; 14:209-214.
8. Rijnen WH, Gardeniers JW, Schreurs BW, Buma P. Impacted bone and calcium phosphate cement for repair of femoral head defects: a pilot study. Clin Orthop Relat Res. 2007;459:216-221.
9. Teixeira CC, Nemelivsky Y, Karkia C, Legeros RZ. Biphasic calcium phosphate: a scaffold for growth plate chondrocyte maturation. Tissue Eng. 2006;12:2283-2289.
10. Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science [Review]. Clin Orthop Relat Res. 2000:10-27.
11. Fleming JE Jr, Cornell CN, Muschler GF. Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am. 2000;31:357-374.
12. Nyman S, Gottlow J, Lindhe J, Karring T, Wennstrom J. New attach-ment formation by guided tissue regeneration. J Periodontal Res. 1987; 22:252-254.
13. Karring T, Warrer K. Development of the principle of guided tissue regeneration. Alpha Omegan. 1992;85:19-24.
14. Hutmacher D, Hurzeler MB, Schliephake H. A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications. Int J Oral Maxillofac Implants. 1996;11: 667-678.
15. Vacanti JP. Beyond transplantation. Third annual Samuel Jason Mixter lecture. Arch Surg. 1988;123:545-549.
16. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A, Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. JPediatr Surg. 1988;23:3-9.
17. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
18. Lee TC, Ho JT, Hung KS, Chen WF, Chung YH, Yang YL. Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment. Neurosurgery. 2006;58:373-380; discussion 373-380.
19. Chen TM, Tsai JC, Burnouf T. Cranioplasty using osteoconductive scaffold and platelet glue. J Trauma. 2008;65:1321-1327.
20. Robb RA, Barillot C. Interactive display and analysis of 3-D medical images. IEEE Trans Med Imaging. 1989;8:217-226.
21. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenviron-ment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17:331-340.
22. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant. 1997;6:125-134.
23. Ringe J, Kaps C, Schmitt B, et al. Porcine mesenchymal stem cells. Induction of distinct mesenchymal cell lineages. Cell TissueRes. 2002; 307:321-327.
24. Yamada Y, Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tis-sue Eng. 2004;10:955-964.
25. Jafarian M, Eslaminejad MB, Khojasteh A, et al. Marrow-derived mesenchymal stem cells-directed bone regeneration in the dog mandible: a comparison between biphasic calcium phosphate and natural bone mineral. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105:e14-e24.
26. Ito K, Yamada Y, Naiki T, Ueda M. Simultaneous implant placement and bone regeneration around dental implants using tissue-engineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implants Res. 2006;17:579-586.
27. Bergel S. Uber Wirkungen des Fibrins. Dtsch Med Wochenschr. 1909; 35:663.
28. Grey EC Fibrin as a hemostatic in cerebral surgery. Surg Gynecol Obstet. 1915;21:452
29. Young JG, Medawar ED. Fibrin suture of peripheral nerves: measure-ment of the rate of regeneration. Lancet. 1940;2:126
30. Tidrick RT, Warner ED. Fibrin fixation of skin transplants. Surgery. 1944;15:90.
31. Matras H, Dinges HP. Zur Nahtlosen interfaszikularen Nerventransplan- tation in Tierexperiment. Wien Med Wochenschr. 1972;122:517.
32. Radosevich M, Goubran HA, Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang. 1997;72:133-143.
33. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials. 2003;24:2497-2502.
34. Wechselberger G, Russell RC, Neumeister MW, Schoeller T, Piza-Katzer H, Rainer C. Successful transplantation of three tissue-engi-neered cell types using capsule induction technique and fibrin glue as a delivery vehicle. Plast Reconstr Surg. 2002;110:123-129.
35. Sierra DH. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J Biomater Appl. 1993;7: 309-352.
36. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638-646.
37. Okuda K, Kawase T, Momose M, et al. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol. 2003;74:849-857.
38. Marx RE. Platelet-rich plasma: evidence to support its use.[see com-ment]. J Oral Maxillofac Surg. 2004;62:489-496.
39. Sanchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants. 2003;18:93-103.
40. Ganio C, Tenewitz FE, Wilson RC, Moyles BG. The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors. JFoot Ankle Surg. 1993;32:263-268.
41. Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T. Platelet-rich plasma enhances human osteoblast-like cell proliferation and dif-ferentiation. J Oral Maxillofac Surg. 2005;63:362-369.
42. Haynesworth SE, Kodiyala SM. Mitogenic stimulation of human mes-enchymal stem cells by platelet releasate suggests a mechanism for enhancement of bone repair by platelet concentrates. Presented at: The 48th Meeting of the Orthopedic Research Society, Dallas, TX, March 2002.
43. Banninger H, Hardegger T, Tobler A, et al. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V.Br J Haematol. 1993;85:528-532.
44. Su CY, Chiang CC, Lai WF, Lin KW, Burnouf T. Platelet-derived growth factor-AB and transforming growth factor-beta 1 in platelet gels activated by single-donor human thrombin. Transfusion. 2004; 44:945.
45. Thorn JJ, Sorensen H, Weis-Fogh U, Andersen M. Autologous fibrin glue with growth factors in reconstructive maxillofacial surgery. Int J Oral Maxillofac Surg. 2004;33:95-100.
46. Zhu S, Choi B, Jung J, et al. A comparative histologic analysis of tissue-engineered bone using platelet-rich plasma and platelet-enriched fibrin glue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;102:175-179.
47. You TM, Choi BH, Zhu SJ, et al. Platelet-enriched fibrin glue and platelet-rich plasma in the repair of bone defects adjacent to titanium dental implants. Int J Oral Maxillofac Implants. 2007;22:417-422.
48. Costantino PD, Friedman CD, Lane A. Synthetic biomaterials in facial plastic and reconstructive surgery. Facial Plast Surg. 1993;9:1-15.